We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-0.67%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$784M
AUM Growth
-$507M
Cap. Flow
-$491M
Cap. Flow %
-62.66%
Top 10 Hldgs %
20.36%
Holding
914
New
32
Increased
9
Reduced
351
Closed
300

Top Buys

Rank Stock Value
1
IBRX icon
ImmunityBio
IBRX
+$41.8M
2
AMRS
Amyris Inc.
AMRS
+$40.6M
3
KPTI icon
Karyopharm Therapeutics
KPTI
+$5.79M
4
RTB
RTB Digital
RTB
+$4.04M
5
XFOR icon
X4 Pharmaceuticals
XFOR
+$3.76M

Top Sells

Rank Stock Value
1
MBAC
M3-Brigade Acquisition II Corp.
MBAC
+$18.9M
2
LGV
Longview Acquisition Corp. II
LGV
+$17.3M
3
GAPA
G&P Acquisition Corp.
GAPA
+$16M
4
KAHC
KKR Acquisition Holdings I Corp.
KAHC
+$13M
5
CFIV
CF Acquisition Corp. IV Class A common stock
CFIV
+$12.8M

Sector Composition

Rank Sector Weight
1 Financials 63.76%
2 Healthcare 12.95%
3 Technology 8.47%
4 Industrials 4.61%
5 Materials 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AERT
251
Aeries Technology
AERT
$35.9M
$305K 0.04%
3,747
-89
-2% -$7.18K
NVOS
252
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$301K 0.04%
+149,453
New +$514K
TRTL
253
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
$299K 0.04%
30,000
– –
DNA.WS
254
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$291K 0.04%
1,456,178
-381,528
-21% -$164K
CLRB icon
255
Cellectar Biosciences
CLRB
$19.8M
$284K 0.04%
+5,535
New +$332K
MRT icon
256
Marti Technologies
MRT
$145M
$282K 0.04%
27,657
– –
POL.WS
257
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$255K 0.03%
3,187,480
-18,273
-0.6% -$1.75K
HMAC
258
DELISTED
Hainan Manaslu Acquisition Corp. Ordinary shares
HMAC
$254K 0.03%
25,000
– –
AFAR
259
DELISTED
Aura FAT Projects Acquisition Corp Class A Ordinary Shares
AFAR
$253K 0.03%
24,582
-418
-2% -$4.24K
SAMA
260
DELISTED
Schultze Special Purpose Acquisition Corp. II Class A Common Stock
SAMA
$247K 0.03%
24,478
– –
NVSA
261
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
$247K 0.03%
24,444
-23,792
-49% -$238K
GTAC
262
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
$239K 0.03%
23,280
-20,529
-47% -$209K
BRSH
263
DELISTED
Bruush Oral Care Inc. Common Stock
BRSH
$234K 0.03%
+20,000
New +$422K
ZURA icon
264
Zura Bio
ZURA
$504M
$233K 0.03%
22,800
-1,800
-7% -$18.2K
JOBY.WS icon
265
Joby Aviation Warrants
JOBY.WS
$228K 0.03%
472,938
-146,278
-24% -$104K
BNNR
266
DELISTED
Banner Acquisition Corp. Class A Common Stock
BNNR
$217K 0.03%
21,500
– –
PALI icon
267
Palisade Bio
PALI
$341M
$208K 0.03%
+2,667
New +$155K
GEEX
268
DELISTED
Games & Esports Experience Acquisition Corp. Class A Ordinary Shares
GEEX
$206K 0.03%
20,034
-815
-4% -$8.32K
UBX
269
CALL
DELISTED
Unity Biotechnology
UBX
$203K 0.03%
74,100
+66,690
+900% +$194K
HUDAR
270
DELISTED
Hudson Acquisition I Corp. Right
HUDAR
$201K 0.03%
+197,000
New +$82.7K
SOC icon
271
Sable Offshore Corp
SOC
$836M
$199K 0.03%
19,771
-44,175
-69% -$441K
HCDIP
272
DELISTED
Harbor Custom Development, Inc. 8.0% Series A Cumulative Convertible Preferred Stock, no par value
HCDIP
$172K 0.02%
26,698
-58,441
-69% -$497K
GWH.WS
273
DELISTED
ESS Tech Inc Warrant
GWH.WS
$166K 0.02%
591,145
– –
NGC
274
DELISTED
Northern Genesis Acquisition Corp. III
NGC
$163K 0.02%
16,196
– –
MTVA
275
MetaVia Inc
MTVA
$7.44M
$154K 0.02%
+2,444
New +$1.05M
9 10
11
12 13

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q4 2022 Portfolio in Review

As of Q4 2022, CVI Holdings held 914 positions worth $784M, down 39% from $1.29B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

CVI Holdings withdrew a net $491M in Q4 2022, closing 300 positions and reducing 351 holdings. Its most notable exit was M3-Brigade Acquisition II Corp., an estimated $18.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 64% of assets, down from 69% a quarter earlier, followed by Healthcare and Technology.

Against the trend, CVI Holdings opened a new position in ImmunityBio worth $38.6M.

  • CVI Holdings's largest Q4 2022 buy was ImmunityBio: 7,609,166 shares worth $38.6M.
  • CVI Holdings added most to Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares in Q4 2022, an estimated $556K increase.
  • CVI Holdings's biggest Q4 2022 reduction was Banzai International, cutting an estimated $4.51M.
  • CVI Holdings fully exited M3-Brigade Acquisition II Corp. in Q4 2022, selling an estimated $18.9M.
  • CVI Holdings's ten largest holdings make up 20% of its $784M portfolio in Q4 2022.
  • CVI Holdings opened 32 new positions and closed 300 in Q4 2022.
  • CVI Holdings's portfolio value fell 39% quarter-over-quarter to $784M.

Based on CVI Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.